SlideShare a Scribd company logo
1 of 20
HYPOTHESIS TESTING
PRESENTED BY:
DR SANJAYA KUMAR SAHOO
PGT,AIIH&PH,KOLKATA
HYPOTHESIS TESTING:
OBJECTIVE:
 To test whether evidence for assumption or statements we make
about our research objectives(i.e alternative hypothesis) against the
previous or existing history of that particular research objective(i.e
null hypothesis)
What is hypothesis?
• Hypothesis is a belief concerning a parameter (i.e statistical constant)
such as prevalence,incidence,population mean,correlation etc.
• Example:
 incidence of TB is higher among low SES groups as compared to
higher SES groups.
Incidece of lung cancer is higher among smokers as compared to non-
smokers.
TESTING OF HYPOTHESES:
• states a hypothesis to be tested,
• formulates an analysis plan,
• analyzes sample data according to
the plan, and
• accepts or rejects the hypothesis,
based on results of the analysis.
The
researcher
5
The scientific hypothesis, is of 2 types:
1.null hypothesis (denoted by H0)
2.alternative hypothesis (denoted by H1).
Thus the alternative hypothesis is the assertion
accepted when null hypothesis is rejected
NULL HYPOTHESIS (H0):
 Null hypothesis is generally a statement that assumes that, there is “NO”
difference between two sets of values.
Examples:
• There is no difference between 2 drugs A & B.
• There is no association between lung cancer and smoking.
• Mean cholesterol level in normals =mean cholesterol level in HTN patients.
ALTERNATIVE HYPOTHESIS(H1)
• It states that there is difference between two sets of values.
Examples:
• There is difference between 2 drugs A & B.
• There is an association between lung cancer and smoking.
• Mean cholesterol values in normals ≠ mean cholesterol in HTN patients.
TYPES OF ERRORS:
TYPE 1 ERROR:
 When null hypothesis H0 is true but still it is rejected type 1 error(alpha error) is
committed .
It is represented as α(alpha) or p-value or level of significance.
Usually P is less than 5 in a hundred(p<0.05)
TYPE II ERROR:
 When null hypothesis H0 is false but it is accepted/fails to reject type-2 error
(beta error) is committed.
 Power of test (1-β) is the ability of test to correctly reject H0(i.e no diff between
the drugs) in favour of H1(i.e there is a difference) when H0 is false.
H0 is true
H0 rejected
H0 is false
H0 accepted
H0 -> μAtorva(A)= μRosuva(B)
Ha->μAtorva(A)≠ μRosuva(B) (2 tailed)
Ha->μAtorva(A)> μRosuva(B) (1 tailed)
Ha->μAtorva(A)< μRosuva(B) (1 tailed)
The power (1-β) of a study
The probability that it correctly
 rejects the null hypothesis(A=B) when the null hypothesis is false.
 accepts the alternative hypothesis(A≠B) when the alternative hypothesis
is true –(It assumes that there is a difference)
 identifies a significant difference or effect or association in the sample
that exists in the population.
The larger the sample size, the study will have greater power
• “Power” is the antithesis of “risk of Type II error”
• Risk of Type II error = 1 – power
• Power = 1 - Risk of Type II error
Type(Alpha) Error Z=standardized
normal deviate
P Z(alpha)
0.05 1.96
0.01 2.57
0.001 3.29
Type(Beta) Error
p Z(beta)
0.10 1.282
0.15 1.037
0.20 0.842
0.25 .675
Hypothesis testing
 When mean is the parameter of the study and
 σ (sigma)→ pooled standard deviation/common
sd between 2 groups
 d → clinically meaningful difference between
two groups/difference between 2 means
 Zα → Z value for α level (type I error)
 Zβ → Z value for β level (type II error)
Estimation of differences between two
means (on quantitative variable like BP,
blood sugar, serum cholesterol etc.)
Requirements:
Estimate of variables of individual values (means &
standard deviations)
Magnitude of differences that is desired to detect(limit
of accuracy required)
Degree of confidence required
The value of the power desired (1-)
 Larger the difference, smaller the trial
size.
 Greater the Power, greater the trial
size.
 Larger the s.d., greater the trial size.
Simple formula When mean is the parameter of
the study :
Sample size in each
group (assumes equal
sized groups)
Represents the
desired power
(typically .84 for 80%
power).
Represents the desired
level of statistical
significance (typically
1.96).
Common Standard deviation between
two groups
σ2 =(n1-1)σ1
2 +(n2-1)σ2
2/(n1+n2)-2
Effect Size (the
difference in
means)
2
2
/2
2
difference
)Z(2  

Z
n
Hypothesis testing:
 When proportion is the parameter of the study and
 p1 → proportion in the first group
 p2 → proportion in the second group
P
 d (p1 - p2 ) → clinically meaningful difference between proportion
of two groups
 Zα → Z value for α level (type I error)
 Zβ → Z value for β level (type II error)
Average of P1 & P2
Estimation of difference between two
proportions
Requirements:
• An estimate of response rate in two groups
• Difference in response rates
• Level of statistical significance ()
• The value of the power desired (1-)
• Whether the test should be one sided or two sided
1.Larger the difference, smaller the trial
size
2. Larger the Power, larger the trial size
3. Absolute value of average P, also
affects trial size
Simple formula when proportion is the
parameter of the study
2
21
2
/2
)(p
)Z)(1)((2
p
Zpp
n


 
Sample size in each
group (assumes equal
sized groups)
Represents the
desired power
(typically .84 for 80%
power).
Represents the
desired level of
statistical
significance
(typically 1.96).
A measure of
variability (similar to
standard deviation)
Effect Size (the
difference in
proportions)
EFFECT SIZE
 Crucial factor : comparative studies
 Smallest measured difference between the comparison
groups
 Unknown, selection of a reasonable difference derived
from pilot studies/lit review/past experience
 ES or the clinically meaningful difference is determined
by the investigator, not by statistician
 For small ES sample size is large
 The investigator may choose a minimum expected
difference of 10%(.1) and this is effect size.
21
THANK YOU

More Related Content

What's hot (20)

Binary OR Binomial logistic regression
Binary OR Binomial logistic regression Binary OR Binomial logistic regression
Binary OR Binomial logistic regression
 
Standard error of the mean
Standard error of the meanStandard error of the mean
Standard error of the mean
 
Binomial distribution
Binomial distributionBinomial distribution
Binomial distribution
 
Testing of hypothesis
Testing of hypothesisTesting of hypothesis
Testing of hypothesis
 
Chi squared test
Chi squared testChi squared test
Chi squared test
 
Standard error
Standard error Standard error
Standard error
 
Sample size calculations
Sample size calculationsSample size calculations
Sample size calculations
 
The Normal distribution
The Normal distributionThe Normal distribution
The Normal distribution
 
Logistic regression
Logistic regressionLogistic regression
Logistic regression
 
Types of error in hypothesis
Types of error in hypothesisTypes of error in hypothesis
Types of error in hypothesis
 
PROBABILITY
PROBABILITYPROBABILITY
PROBABILITY
 
Binomial distribution
Binomial distributionBinomial distribution
Binomial distribution
 
Type I and Type II Errors in Research Methodology
Type I and Type II Errors in Research MethodologyType I and Type II Errors in Research Methodology
Type I and Type II Errors in Research Methodology
 
T test
T testT test
T test
 
3.5.2 selection bias
3.5.2 selection bias3.5.2 selection bias
3.5.2 selection bias
 
Brm (one tailed and two tailed hypothesis)
Brm (one tailed and two tailed hypothesis)Brm (one tailed and two tailed hypothesis)
Brm (one tailed and two tailed hypothesis)
 
Confidence interval
Confidence intervalConfidence interval
Confidence interval
 
Kruskal wallis test
Kruskal wallis testKruskal wallis test
Kruskal wallis test
 
Covariance vs Correlation
Covariance vs CorrelationCovariance vs Correlation
Covariance vs Correlation
 
Basics of biostatistic
Basics of biostatisticBasics of biostatistic
Basics of biostatistic
 

Similar to Hypothesis testing lectures

Testing the hypothesis
Testing the hypothesisTesting the hypothesis
Testing the hypothesisJen Millan
 
Inferential statistics
Inferential statisticsInferential statistics
Inferential statisticsAshok Kulkarni
 
inferentialstatistics-210411214248.pdf
inferentialstatistics-210411214248.pdfinferentialstatistics-210411214248.pdf
inferentialstatistics-210411214248.pdfChenPalaruan
 
Ch 12 SIGNIFICANT TESTrr.doc
Ch 12 SIGNIFICANT TESTrr.docCh 12 SIGNIFICANT TESTrr.doc
Ch 12 SIGNIFICANT TESTrr.docAbedurRahman5
 
Parametric tests seminar
Parametric tests seminarParametric tests seminar
Parametric tests seminardrdeepika87
 
Unit 9b. Sample size estimation.ppt
Unit 9b. Sample size estimation.pptUnit 9b. Sample size estimation.ppt
Unit 9b. Sample size estimation.pptshakirRahman10
 
P-Value: a true test of significance in agricultural research
P-Value: a true test of significance in agricultural researchP-Value: a true test of significance in agricultural research
P-Value: a true test of significance in agricultural researchJiban Shrestha
 
Tests for one-sample_sensitivity_and_specificity
Tests for one-sample_sensitivity_and_specificityTests for one-sample_sensitivity_and_specificity
Tests for one-sample_sensitivity_and_specificityTulio Batista Veras
 
Testing hypothesis
Testing hypothesisTesting hypothesis
Testing hypothesisAmit Sharma
 
Testing of Hypothesis, p-value, Gaussian distribution, null hypothesis
Testing of Hypothesis, p-value, Gaussian distribution, null hypothesisTesting of Hypothesis, p-value, Gaussian distribution, null hypothesis
Testing of Hypothesis, p-value, Gaussian distribution, null hypothesissvmmcradonco1
 
introduction to biostatistics in clinical trials
introduction to biostatistics in clinical trialsintroduction to biostatistics in clinical trials
introduction to biostatistics in clinical trialsstopit2404
 
introduction to biostatistics in clinical trials
introduction to biostatistics in clinical trialsintroduction to biostatistics in clinical trials
introduction to biostatistics in clinical trialsstopit2404
 
Statistical analysis in pharmacokinetics.pptx
Statistical analysis in pharmacokinetics.pptxStatistical analysis in pharmacokinetics.pptx
Statistical analysis in pharmacokinetics.pptxMdHimelAhmedRidoy1
 
Chapter 28 clincal trials
Chapter 28 clincal trials Chapter 28 clincal trials
Chapter 28 clincal trials Nilesh Kucha
 
Medical Statistics Pt 1
Medical Statistics Pt 1Medical Statistics Pt 1
Medical Statistics Pt 1Fastbleep
 

Similar to Hypothesis testing lectures (20)

Testing the hypothesis
Testing the hypothesisTesting the hypothesis
Testing the hypothesis
 
Inferential statistics
Inferential statisticsInferential statistics
Inferential statistics
 
Overview of statistics: Statistical testing (Part I)
Overview of statistics: Statistical testing (Part I)Overview of statistics: Statistical testing (Part I)
Overview of statistics: Statistical testing (Part I)
 
inferentialstatistics-210411214248.pdf
inferentialstatistics-210411214248.pdfinferentialstatistics-210411214248.pdf
inferentialstatistics-210411214248.pdf
 
Inferential statistics
Inferential statisticsInferential statistics
Inferential statistics
 
Ch 12 SIGNIFICANT TESTrr.doc
Ch 12 SIGNIFICANT TESTrr.docCh 12 SIGNIFICANT TESTrr.doc
Ch 12 SIGNIFICANT TESTrr.doc
 
Parametric tests seminar
Parametric tests seminarParametric tests seminar
Parametric tests seminar
 
Unit 9b. Sample size estimation.ppt
Unit 9b. Sample size estimation.pptUnit 9b. Sample size estimation.ppt
Unit 9b. Sample size estimation.ppt
 
Unit 3
Unit 3Unit 3
Unit 3
 
P-Value: a true test of significance in agricultural research
P-Value: a true test of significance in agricultural researchP-Value: a true test of significance in agricultural research
P-Value: a true test of significance in agricultural research
 
Tests for one-sample_sensitivity_and_specificity
Tests for one-sample_sensitivity_and_specificityTests for one-sample_sensitivity_and_specificity
Tests for one-sample_sensitivity_and_specificity
 
Sample size calculation final
Sample size calculation finalSample size calculation final
Sample size calculation final
 
Testing hypothesis
Testing hypothesisTesting hypothesis
Testing hypothesis
 
Testing of Hypothesis, p-value, Gaussian distribution, null hypothesis
Testing of Hypothesis, p-value, Gaussian distribution, null hypothesisTesting of Hypothesis, p-value, Gaussian distribution, null hypothesis
Testing of Hypothesis, p-value, Gaussian distribution, null hypothesis
 
introduction to biostatistics in clinical trials
introduction to biostatistics in clinical trialsintroduction to biostatistics in clinical trials
introduction to biostatistics in clinical trials
 
introduction to biostatistics in clinical trials
introduction to biostatistics in clinical trialsintroduction to biostatistics in clinical trials
introduction to biostatistics in clinical trials
 
Statistical analysis in pharmacokinetics.pptx
Statistical analysis in pharmacokinetics.pptxStatistical analysis in pharmacokinetics.pptx
Statistical analysis in pharmacokinetics.pptx
 
Biostatistics.pptx
Biostatistics.pptxBiostatistics.pptx
Biostatistics.pptx
 
Chapter 28 clincal trials
Chapter 28 clincal trials Chapter 28 clincal trials
Chapter 28 clincal trials
 
Medical Statistics Pt 1
Medical Statistics Pt 1Medical Statistics Pt 1
Medical Statistics Pt 1
 

Recently uploaded

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 

Recently uploaded (20)

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 

Hypothesis testing lectures

  • 1. HYPOTHESIS TESTING PRESENTED BY: DR SANJAYA KUMAR SAHOO PGT,AIIH&PH,KOLKATA
  • 2. HYPOTHESIS TESTING: OBJECTIVE:  To test whether evidence for assumption or statements we make about our research objectives(i.e alternative hypothesis) against the previous or existing history of that particular research objective(i.e null hypothesis)
  • 3. What is hypothesis? • Hypothesis is a belief concerning a parameter (i.e statistical constant) such as prevalence,incidence,population mean,correlation etc. • Example:  incidence of TB is higher among low SES groups as compared to higher SES groups. Incidece of lung cancer is higher among smokers as compared to non- smokers.
  • 4. TESTING OF HYPOTHESES: • states a hypothesis to be tested, • formulates an analysis plan, • analyzes sample data according to the plan, and • accepts or rejects the hypothesis, based on results of the analysis. The researcher 5
  • 5. The scientific hypothesis, is of 2 types: 1.null hypothesis (denoted by H0) 2.alternative hypothesis (denoted by H1). Thus the alternative hypothesis is the assertion accepted when null hypothesis is rejected
  • 6. NULL HYPOTHESIS (H0):  Null hypothesis is generally a statement that assumes that, there is “NO” difference between two sets of values. Examples: • There is no difference between 2 drugs A & B. • There is no association between lung cancer and smoking. • Mean cholesterol level in normals =mean cholesterol level in HTN patients.
  • 7. ALTERNATIVE HYPOTHESIS(H1) • It states that there is difference between two sets of values. Examples: • There is difference between 2 drugs A & B. • There is an association between lung cancer and smoking. • Mean cholesterol values in normals ≠ mean cholesterol in HTN patients.
  • 8. TYPES OF ERRORS: TYPE 1 ERROR:  When null hypothesis H0 is true but still it is rejected type 1 error(alpha error) is committed . It is represented as α(alpha) or p-value or level of significance. Usually P is less than 5 in a hundred(p<0.05) TYPE II ERROR:  When null hypothesis H0 is false but it is accepted/fails to reject type-2 error (beta error) is committed.  Power of test (1-β) is the ability of test to correctly reject H0(i.e no diff between the drugs) in favour of H1(i.e there is a difference) when H0 is false.
  • 9. H0 is true H0 rejected H0 is false H0 accepted
  • 10. H0 -> μAtorva(A)= μRosuva(B) Ha->μAtorva(A)≠ μRosuva(B) (2 tailed) Ha->μAtorva(A)> μRosuva(B) (1 tailed) Ha->μAtorva(A)< μRosuva(B) (1 tailed)
  • 11. The power (1-β) of a study The probability that it correctly  rejects the null hypothesis(A=B) when the null hypothesis is false.  accepts the alternative hypothesis(A≠B) when the alternative hypothesis is true –(It assumes that there is a difference)  identifies a significant difference or effect or association in the sample that exists in the population. The larger the sample size, the study will have greater power • “Power” is the antithesis of “risk of Type II error” • Risk of Type II error = 1 – power • Power = 1 - Risk of Type II error
  • 12. Type(Alpha) Error Z=standardized normal deviate P Z(alpha) 0.05 1.96 0.01 2.57 0.001 3.29 Type(Beta) Error p Z(beta) 0.10 1.282 0.15 1.037 0.20 0.842 0.25 .675
  • 13. Hypothesis testing  When mean is the parameter of the study and  σ (sigma)→ pooled standard deviation/common sd between 2 groups  d → clinically meaningful difference between two groups/difference between 2 means  Zα → Z value for α level (type I error)  Zβ → Z value for β level (type II error)
  • 14. Estimation of differences between two means (on quantitative variable like BP, blood sugar, serum cholesterol etc.) Requirements: Estimate of variables of individual values (means & standard deviations) Magnitude of differences that is desired to detect(limit of accuracy required) Degree of confidence required The value of the power desired (1-)  Larger the difference, smaller the trial size.  Greater the Power, greater the trial size.  Larger the s.d., greater the trial size.
  • 15. Simple formula When mean is the parameter of the study : Sample size in each group (assumes equal sized groups) Represents the desired power (typically .84 for 80% power). Represents the desired level of statistical significance (typically 1.96). Common Standard deviation between two groups σ2 =(n1-1)σ1 2 +(n2-1)σ2 2/(n1+n2)-2 Effect Size (the difference in means) 2 2 /2 2 difference )Z(2    Z n
  • 16. Hypothesis testing:  When proportion is the parameter of the study and  p1 → proportion in the first group  p2 → proportion in the second group P  d (p1 - p2 ) → clinically meaningful difference between proportion of two groups  Zα → Z value for α level (type I error)  Zβ → Z value for β level (type II error) Average of P1 & P2
  • 17. Estimation of difference between two proportions Requirements: • An estimate of response rate in two groups • Difference in response rates • Level of statistical significance () • The value of the power desired (1-) • Whether the test should be one sided or two sided 1.Larger the difference, smaller the trial size 2. Larger the Power, larger the trial size 3. Absolute value of average P, also affects trial size
  • 18. Simple formula when proportion is the parameter of the study 2 21 2 /2 )(p )Z)(1)((2 p Zpp n     Sample size in each group (assumes equal sized groups) Represents the desired power (typically .84 for 80% power). Represents the desired level of statistical significance (typically 1.96). A measure of variability (similar to standard deviation) Effect Size (the difference in proportions)
  • 19. EFFECT SIZE  Crucial factor : comparative studies  Smallest measured difference between the comparison groups  Unknown, selection of a reasonable difference derived from pilot studies/lit review/past experience  ES or the clinically meaningful difference is determined by the investigator, not by statistician  For small ES sample size is large  The investigator may choose a minimum expected difference of 10%(.1) and this is effect size. 21